News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,230 Results
Type
Article (284)
Press Release (946)
Section
Business (412)
Deals (20)
Drug Development (465)
Employer Resources (1)
FDA (42)
Job Trends (33)
News (729)
Policy (134)
Tag
Academia (12)
Alliances (90)
Approvals (41)
Bankruptcy (1)
Best Places to Work (24)
Clinical research (228)
COVID-19 (208)
Data (2)
Diagnostics (28)
Drug shortages (1)
Earnings (170)
Employer resources (1)
Events (177)
Executive appointments (1)
FDA (45)
GLP-1 (7)
Government (67)
Healthcare (52)
Infectious disease (208)
Influenza (3)
IPO (12)
Job creations (8)
Layoffs (2)
Legal (7)
Manufacturing (4)
Medical device (11)
Medtech (11)
Mergers & acquisitions (9)
Metabolic disorders (3)
NextGen Class of 2024 (9)
Non-profit (6)
Obesity (1)
Opinion (1)
People (132)
Phase I (110)
Phase II (142)
Phase III (111)
Pipeline (2)
Preclinical (66)
Press Release (1)
Rare diseases (1)
Real estate (12)
Recruiting (1)
Regulatory (80)
Research institute (17)
Startups (5)
Supply chain (2)
United States (26)
Vaccines (57)
Weight loss (3)
Date
Last 7 days (5)
Last 30 days (10)
Last 365 days (51)
2024 (51)
2023 (67)
2022 (152)
2021 (194)
2020 (194)
2019 (23)
2018 (18)
2017 (35)
2016 (42)
2015 (50)
2014 (50)
2013 (35)
2012 (40)
2011 (40)
2010 (46)
Location
Africa (4)
Asia (74)
Australia (9)
Canada (1)
Europe (107)
Florida (1)
Maryland (19)
Massachusetts (1)
New Jersey (1)
New York (2)
Pennsylvania (1)
South America (2)
1,230 Results for "novavax".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
UPDATE: FDA Lifts Clinical Hold on Novavax’s COVID/Flu Vaccine Candidates, Clears Phase III Trial
Novavax’s shared jumped 12% in pre-market trading on the news.
November 11, 2024
·
2 min read
·
Annalee Armstrong
COVID-19
Novavax Catches Up to Competitors With FDA Approval for Updated COVID-19 Boosters
Unlike Pfizer/BioNTech and Moderna, Novavax does not use mRNA technology for its COVID-19 vaccine, instead opting for a recombinant version of the virus’ spike protein to elicit protection.
September 3, 2024
·
2 min read
·
Tristan Manalac
BioCapital
Novavax to Participate in 2024 Jefferies Global Healthcare Conference
Novavax, Inc. today announced it will participate in the 2024 Jefferies Global Healthcare Conference.
May 30, 2024
·
1 min read
Press Releases
Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 Million
December 4, 2024
·
5 min read
Press Releases
Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza
December 10, 2024
·
6 min read
Press Releases
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone
December 13, 2024
·
5 min read
Press Releases
Novavax Reports Third Quarter 2024 Financial Results and Operational Highlights
November 13, 2024
·
14 min read
BioCapital
Novavax to Participate in BofA Securities 2024 Health Care Conference
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will participate in the BofA Securities 2024 Health Care Conference.
May 13, 2024
·
1 min read
Novavax Soars on $1.4B Deal With Sanofi for COVID Vaccine
Sanofi will hand Novavax $500 million upfront for its COVID-19 vaccine, which it will co-commercialize and develop into a combination flu-COVID vaccine.
May 10, 2024
·
1 min read
·
Kate Goodwin
Press Releases
Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)
November 15, 2024
·
2 min read
1 of 123
Next
